FTI Consulting, Inc. (NYSE:FCN) shares moved up 2.49% in last trading session and ended the day at $44.04. FCN Gross Margin is 34.80% and its has a return on assets of 2.90%. FTI Consulting, Inc. (NYSE:FCN) quarterly performance is 3.77%.
FTI Consulting, Inc. (NYSE:FCN), released initial findings from the 2015 Shareholder Activism Survey, which finds that activist investing continues to garner strong capital support from investors and wider acceptance from corporate stakeholders. Building on last year’s inaugural study, this year’s survey reveals that activists are getting more support from institutional investors and are looking outside the U.S. for new investments.
Care.com, Inc. (NYSE:CRCM) ended the last trading day at $5.51. Company weekly volatility is calculated as 3.96% and price to cash ratio as 3.13. Care.com, Inc. (NYSE:CRCM) showed a weekly performance of 9.98%.
Care.com (NYSE: CRCM), announced the launch of its first transactional app, Date NightSM by Care.com, which provides a comprehensive experience for parents looking for an occasional babysitter. The Date Night app offers time-starved parents the ability to plan a complete date night with ease — from finding, interviewing, booking, and paying available sitters, to securing restaurant reservations through OpenTable and worry-free movie tickets through Fandango.
On 05 October, AU Optronics Corp. (NYSE:AUO) shares moved up 1.99% and was closed at $3.08. AUO EPS growth in last 5 year was 20.30%. AU Optronics Corp. (NYSE:AUO) year to date (YTD) performance is -37.12%.
AU Optronics Corp. (NYSE:AUO) reports preliminary financial results for the quarter ended June 30, 2015. Revenues of USD 3,004.48 million, Net Earnings of USD 146.31 million, and Earnings per Share (EPS) of USD 0.15.Gross margins widened from 9.27% to 11.65% compared to the same quarter last year, operating (EBITDA) margins now 20.24% from 17.99%.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shares moved up 2.93% in last trading session and ended the day at $39.03. Its has a return on assets of 31.90%. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) quarterly performance is -13.27%.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) announced that 34 abstracts from AbbVie’s chronic hepatitis C clinical development program have been accepted for presentation at the Liver Meeting®, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) taking place November 13-17, 2015 in San Francisco.
Civeo Corporation (NYSE:CVEO) caters to the Services space. It has a net profit margin of -32.40% and weekly performance is 14.37%. On the last day of trading company shares ended up at $1.83. Civeo Corporation (NYSE:CVEO) distance from 50-day simple moving average (SMA50) is 5.85%.
Analysts at Zacks have given a short term rating of hold on Civeo Corporation (NYSE:CVEO) with a rank of 3. The company has received an average rating of 1.5 from 4 brokerage firms.
Leave a Reply